We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Slams Indian Drugmaker Wockhardt Over String of GMP Lapses
FDA Slams Indian Drugmaker Wockhardt Over String of GMP Lapses
An FDA inspection uncovered a host of GMP deficiencies at a Wockhardt production plant in India, despite earlier attempts by the company to downplay the findings.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor